GO:0008432 JUN kinase binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008432 (JUN kinase binding) is a molecular function describing the selective binding of a protein to JUN kinase (JNK), the enzyme that phosphorylates and activates JUN family transcription factors.
• JNK binding is a critical step in the JNK signaling cascade, which transmits stress and cytokine signals from small GTPases Rac1 and Cdc42 through mixed lineage kinase 3 (MLK3) to JNK.
• Scaffold proteins such as JNK-interacting protein 4 (JIP4) bind JNK and modulate downstream phosphorylation of MKK4, p38, and JNK, thereby influencing apoptosis.
• Dysregulated JNK binding and signaling are implicated in cancer cell transformation, apoptosis, and stress responses, making this function a target for experimental modeling.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise interrogation of JUN kinase binding interfaces and their cellular consequences.
• Understanding GO:0008432 helps researchers design targeted experiments to dissect kinase-substrate interactions and develop therapeutics for JNK-related diseases.
Description
JUN kinase binding (GO:0008432) is a molecular function that defines the physical interaction between a protein and JUN kinase (JNK), a member of the mitogen-activated protein kinase (MAPK) family. JNK catalyzes the phosphorylation and activation of JUN family transcription factors, which are key regulators of gene expression in response to stress, cytokines, and growth factors. This binding event is essential for assembling signaling complexes that propagate extracellular cues to nuclear responses. Researchers study JUN kinase binding to understand how specificity is achieved in MAPK cascades and how dysregulation contributes to diseases such as cancer and neurodegeneration. The interaction between JNK and its binding partners, including scaffold proteins like JIP4, modulates downstream phosphorylation events and cellular outcomes such as apoptosis. Small GTPases Rac1 and Cdc42 signal through mixed lineage kinase 3 (MLK3) to activate the JNK pathway, highlighting the importance of protein-protein interactions in this cascade. Thus, GO:0008432 represents a focal point for investigating signal transduction mechanisms and for developing targeted interventions.
JUN kinase binding At A Glance
| GO ID | GO:0008432 |
|---|---|
| GO term | JUN kinase binding |
| Ontology | molecular_function |
| Synonym | JNK binding |
| Definition | Binding to JUN kinase, an enzyme that catalyzes the phosphorylation and activation of members of the JUN family. |
| Major function | Mediates protein-protein interactions that localize JNK to substrates and regulate downstream signaling. |
| Related pathway | JNK/MAPK stress-activated signaling cascade. |
| Key interactors | JNK, JIP4, MKK4, MLK3, Rac1, Cdc42. |
What Is GO:0008432?
In simple terms, JUN kinase binding is the ability of a protein to attach to JNK, the enzyme that turns on JUN transcription factors. According to the QuickGO definition, it is the binding to JUN kinase, an enzyme that catalyzes the phosphorylation and activation of members of the JUN family. This function is a molecular activity that facilitates the assembly of signaling complexes and ensures proper substrate targeting.
Why Is JUN kinase binding Important in Cell Biology?
JUN kinase binding is important because it governs the specificity and efficiency of JNK-mediated phosphorylation of JUN transcription factors, which control gene expression programs involved in cell survival, apoptosis, and differentiation. Disruption of this binding can alter stress responses and contribute to pathological conditions such as cancer and inflammatory diseases. Understanding the molecular details of JUN kinase binding provides a foundation for designing experiments to modulate this interaction for therapeutic benefit.
• Controls activation of JUN family transcription factors in response to stress and cytokines.
• Integrates signals from small GTPases Rac1 and Cdc42 through MLK3 to JNK.
• Scaffold proteins like JIP4 bind JNK and modulate downstream MKK4, p38, and JNK phosphorylation.
• Dysregulation is linked to cancer cell transformation and apoptosis.
• Provides a target for experimental perturbation using CRISPR-based models.
• Essential for understanding MAPK cascade specificity and crosstalk.
• Relevant to neurodegenerative and inflammatory diseases where JNK signaling is aberrant.
• Facilitates design of peptide or small-molecule inhibitors of JNK interactions.
• Enables functional annotation of uncharacterized JNK-binding proteins.
• Supports development of biomarkers for JNK pathway activity.
What Happens During JUN kinase binding?
Recognition and docking of JNK by binding partners
In simple terms: First, a protein recognizes and grabs onto JNK.
JUN kinase binding begins with the selective recognition of JNK by a binding partner, often through a docking motif or scaffold domain. For example, JIP4 binds JNK and modulates its activity. This interaction is critical for localizing JNK to specific substrates and signaling complexes. Small GTPases Rac1 and Cdc42 initiate the cascade by activating MLK3, which then leads to JNK activation and binding to downstream effectors.
Formation of signaling complexes
In simple terms: The binding brings JNK together with other proteins to form a signaling team.
Once bound, JNK assembles into multiprotein complexes that include upstream kinases like MKK4 and scaffold proteins. Tanaka et al. showed that knockdown of Sec8 enhances the binding affinity of JIP4 for MKK4 and suppresses phosphorylation of MKK4, p38, and JNK, thereby inhibiting apoptosis. This illustrates how JUN kinase binding is embedded in a network of interactions that determine signaling outcomes.
Phosphorylation and activation of JUN substrates
In simple terms: JNK then adds phosphate groups to JUN proteins, turning them on.
The ultimate consequence of JUN kinase binding is the phosphorylation of JUN family transcription factors. This modification activates JUN, allowing it to regulate target genes involved in stress responses, proliferation, and apoptosis. The binding event ensures that JNK is positioned correctly to phosphorylate JUN efficiently. Zhu et al. demonstrated that COOH-terminal Src kinase-mediated c-Jun phosphorylation promotes c-Jun degradation and inhibits cell transformation, highlighting the importance of phosphorylation in JUN regulation.
Feedback and regulation of binding
In simple terms: The binding can be turned up or down by other signals.
JUN kinase binding is subject to regulation by upstream signals and feedback loops. For instance, the eIF2α/ATF4 pathway is essential for stress-induced autophagy gene expression, which may intersect with JNK signaling. Additionally, ATP binding is a key target for control of the chemotaxis kinase, suggesting that nucleotide binding can modulate kinase interactions. These regulatory layers ensure that JUN kinase binding is dynamic and context-dependent.
Key Genes Involved in GO:0008432 JUN kinase binding
The following genes and proteins are central to JUN kinase binding and its downstream signaling.
| Gene | Major Role | Research Relevance |
|---|---|---|
| JNK | JUN kinase; phosphorylates JUN family transcription factors | Core enzyme in the binding function; target for knockout and point mutation studies |
| JUN | Transcription factor activated by JNK phosphorylation | Downstream effector; key readout of JUN kinase binding |
| JIP4 | Scaffold protein that binds JNK and MKK4 | Modulates binding affinity and downstream phosphorylation |
| MKK4 | Upstream kinase that activates JNK | Component of signaling complex; phosphorylation target |
| MLK3 | Mixed lineage kinase that activates JNK pathway | Links Rac1/Cdc42 to JNK |
| Rac1 | Small GTPase that signals to JNK | Upstream regulator of JUN kinase binding |
| Cdc42 | Small GTPase that signals to JNK | Upstream regulator of JUN kinase binding |
| Sec8 | Exocyst component; knockdown enhances JIP4-MKK4 binding | Regulator of JNK binding and apoptosis |
| p38 | MAPK family member; phosphorylation suppressed by JIP4 binding | Crosstalk with JNK pathway |
| ATF4 | Stress-induced transcription factor | May intersect with JNK signaling |
| TPR4 | Regeneration-related protein | Potential link to stress signaling |
| ERF115 | Regeneration-related transcription factor | Potential link to stress signaling |
| CSK | COOH-terminal Src kinase; phosphorylates c-Jun | Regulates c-Jun degradation |
| Calmodulin | Calcium-binding protein | Potential modulator of kinase interactions |
| Insulin receptor | Receptor tyrosine kinase | Model for soluble binder design |
| Chemotaxis kinase | Bacterial kinase controlled by ATP binding | Model for nucleotide-dependent regulation |
| FERONIA | Plant receptor kinase | Model for kinase signaling in regeneration |
How Is JUN kinase binding Regulated?
JUN kinase binding is regulated at multiple levels. Upstream small GTPases Rac1 and Cdc42 activate MLK3, which in turn activates JNK and promotes its binding to substrates. Scaffold proteins such as JIP4 can enhance or inhibit binding affinity; knockdown of Sec8 enhances JIP4 binding to MKK4 and suppresses downstream phosphorylation. Additionally, stress-induced pathways like the eIF2α/ATF4 pathway may influence JNK signaling and autophagy gene expression. ATP binding can control kinase activity and interactions, as shown for the chemotaxis kinase. These regulatory mechanisms ensure that JUN kinase binding is tightly controlled in response to cellular conditions.
JUN kinase binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| JNK | Cancer, neurodegeneration, inflammation | Knockout and point mutation cell lines |
| JUN | Cancer cell transformation | Overexpression and knock-in models |
| JIP4 | Apoptosis regulation | Knockdown and knockout models |
| MLK3 | Neurodegeneration | Knockout and point mutation models |
| Rac1 | Cancer, inflammation | Overexpression and knockout models |
Cancer
Dysregulated JUN kinase binding and JNK signaling contribute to cancer development. Zhu et al. showed that COOH-terminal Src kinase-mediated c-Jun phosphorylation promotes c-Jun degradation and inhibits cell transformation, indicating that proper regulation of JUN activity is critical for preventing oncogenesis. Altered JUN kinase binding could disrupt this balance, leading to uncontrolled proliferation.
Neurodegeneration
JNK signaling is implicated in neuronal stress responses and neurodegeneration. The MLK3-Rac1/Cdc42 pathway that activates JNK is a key mediator of stress-induced neuronal death. Disruption of JUN kinase binding may alter these responses, contributing to disease progression.
Inflammatory diseases
JNK pathway activation is a hallmark of inflammatory signaling. JUN kinase binding facilitates the phosphorylation of JUN transcription factors that drive expression of inflammatory cytokines. Targeting this interaction could provide therapeutic benefits in chronic inflammation.
From JUN kinase binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of JNK binding affect JUN phosphorylation? | JNK knockout cell line |
| How do point mutations in the JNK docking site alter binding affinity? | Point mutation knock-in of JNK |
| Can a tagged JNK be used to pull down binding partners? | Tagged knock-in of JNK |
| What is the effect of JIP4 overexpression on apoptosis? | Overexpression of JIP4 |
| Does MLK3 knockout disrupt Rac1-Cdc42 signaling to JNK? | MLK3 knockout |
| Can CRISPR library screening identify novel JNK binding regulators? | Genome-wide CRISPR knockout library |
How to Study the JUN kinase binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Co-immunoprecipitation | Protein-protein interactions | Detecting JUN kinase binding in cell lysates |
| GST pull-down | Direct binding affinity | Mapping interaction domains |
| In vitro kinase assay | Phosphorylation activity | Measuring JNK-mediated JUN phosphorylation |
| Western blot | Protein expression and phosphorylation | Validating binding effects on signaling |
| CRISPR knockout | Gene function loss | Identifying regulators of JUN kinase binding |
| CRISPR activation | Gene overexpression | Enhancing binding partner expression |
| Structural biology | 3D structure of complexes | Designing inhibitors of JUN kinase binding |
| Bioinformatics | Pathway and network analysis | Predicting novel JNK binding partners |
Co-immunoprecipitation and pull-down assays
Co-immunoprecipitation (co-IP) and GST pull-down assays are standard methods to detect and quantify JUN kinase binding. These techniques use tagged JNK or binding partners to isolate complexes from cell lysates, followed by western blotting. Tanaka et al. used such approaches to show that Sec8 knockdown enhances JIP4 binding to MKK4.
Phosphorylation assays
In vitro kinase assays and phospho-specific antibodies measure JNK-mediated phosphorylation of JUN substrates. These assays can be coupled with binding studies to correlate interaction strength with catalytic activity.
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can identify genes that regulate JUN kinase binding and downstream signaling. Such screens are powerful for discovering novel components of the JNK pathway.
Structural biology and modeling
X-ray crystallography, cryo-EM, and molecular modeling provide atomic-level insights into the JNK-binding interface. These methods help rationalize how mutations affect binding affinity and specificity.
How CRISPR Can Be Used to Study GO:0008432 JUN kinase binding
Knockout
CRISPR knockout of JNK or its binding partners can abolish JUN kinase binding and reveal downstream effects on JUN phosphorylation and cellular phenotypes. For example, knocking out JIP4 or MLK3 would disrupt the signaling complex and help define their roles.
Point Mutation
Point mutations in the JNK docking site or in binding partners can be introduced to fine-tune binding affinity. Such models are useful for dissecting the contribution of specific residues to JUN kinase binding without completely eliminating the protein.
Knock-in
Knock-in of tagged JNK (e.g., GFP or HA) allows for affinity purification and imaging of JUN kinase binding in live cells. This approach enables real-time tracking of interactions and complex assembly.
Overexpression
Overexpression of JNK or its binding partners can amplify JUN kinase binding and downstream signaling, providing a gain-of-function system to study pathway activation and identify dose-dependent effects.
How EDITGENE Supports JUN kinase binding Research
Researchers studying JUN kinase binding-related genes often need to determine whether a candidate gene is causally involved in the interaction or downstream signaling. EDITGENE provides a comprehensive suite of CRISPR-based services to create precisely engineered cell models that answer these questions.
Contact EDITGENE today to design your custom CRISPR model for JUN kinase binding research.
Frequently Asked Questions About JUN kinase binding
What is JUN kinase binding?
JUN kinase binding (GO:0008432) is the molecular function of a protein binding to JUN kinase (JNK), the enzyme that phosphorylates and activates JUN family transcription factors.
What genes are involved in JUN kinase binding?
Key genes include JNK, JUN, JIP4, MKK4, MLK3, Rac1, and Cdc42, which form the core signaling module.
How is JUN kinase binding regulated?
It is regulated by upstream GTPases Rac1 and Cdc42, scaffold proteins like JIP4, and feedback phosphorylation events.
What diseases are associated with JUN kinase binding?
Dysregulation is linked to cancer, neurodegeneration, and inflammatory diseases.
What methods are used to study JUN kinase binding?
Common methods include co-immunoprecipitation, pull-down assays, kinase assays, CRISPR screens, and structural biology.
Can CRISPR be used to study JUN kinase binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect this interaction.
What is the role of JIP4 in JUN kinase binding?
JIP4 is a scaffold protein that binds JNK and MKK4, modulating downstream phosphorylation and apoptosis.
How does MLK3 activate JUN kinase binding?
MLK3 is activated by Rac1 and Cdc42 and phosphorylates downstream kinases that lead to JNK activation and binding.
What is the clinical relevance of JUN kinase binding?
It is a potential therapeutic target for cancers and inflammatory diseases where JNK signaling is aberrant.
Where can I find CRISPR models for JUN kinase binding research?
EDITGENE provides custom knockout, point mutation, knock-in, and overexpression models for JUN kinase binding studies.
Conclusion
JUN kinase binding (GO:0008432) is a fundamental molecular function that orchestrates JNK-mediated phosphorylation of JUN transcription factors, influencing cell fate decisions in health and disease. Understanding its mechanisms, regulation, and disease links provides a rich area for biomedical research. EDITGENE offers advanced CRISPR solutions to accelerate discoveries in this field.
References
- 1. B'chir W et al.. 2013. The eIF2α/ATF4 pathway is essential for stress-induced autophagy gene expression.. Nucleic Acids Res 41(16):7683-99 PMID: 23804767
- 2. Shen Y et al.. 2025. RALF33-FERONIA signaling orchestrates postwounding root-tip regeneration via TPR4-ERF115 dynamics.. Plant Cell 37(6) PMID: 40323783
- 3. Jun SY et al.. 2020. ATP Binding as a Key Target for Control of the Chemotaxis Kinase.. J Bacteriol 202(13) PMID: 32341073
- 4. Mendoza C et al.. 2023. Insulin receptor-inspired soluble insulin binder.. Eur J Cell Biol 102(2):151293 PMID: 36739671
- 5. Tanaka T et al.. 2014. Knockdown of Sec8 enhances the binding affinity of c-Jun N-terminal kinase (JNK)-interacting protein 4 for mitogen-activated protein kinase kinase 4 (MKK4) and suppresses the phosphorylation of MKK4, p38, and JNK, thereby inhibiting apoptosis.. FEBS J 281(23):5237-50 PMID: 25244576
- 6. Lin YM. 1982. Calmodulin.. Mol Cell Biochem 45(2):101-12 PMID: 6287204
- 7. Zhu F et al.. 2006. COOH-terminal Src kinase-mediated c-Jun phosphorylation promotes c-Jun degradation and inhibits cell transformation.. Cancer Res 66(11):5729-36 PMID: 16740711
- 8. Teramoto H et al.. 1996. Signaling from the small GTP-binding proteins Rac1 and Cdc42 to the c-Jun N-terminal kinase/stress-activated protein kinase pathway. A role for mixed lineage kinase 3/protein-tyrosine kinase 1, a novel member of the mixed lineage kinase family.. J Biol Chem 271(44):27225-8 PMID: 8910292
